CVS Health Corp (CVS) News Today: Latest Market and Industry Updates

80.84
0.7900
0.99 %
Daily range
Weekly range
  • Ashutosh Sureka
  • 18.11.2026
CVS slides over 3% as bearish momentum persists amid split plans and regulatory concerns
CVS Health Corp (CVS) fell 3.4% after the company's plan to split into two independent publicly traded entities weighed on investor sentiment. The move is supported by pronounced technical ...
  • Ezequiel Gomes
  • 17.11.2026
CVS Health shares technical analysis: Downward momentum persists near $83.81 support
CVS Health (CVS) stock is trading at $85.21, reflecting a daily decline of 3.83%. The share price is positioned below its key moving averages, indicating broad seller ...
  • Olga Shendetskaya
  • 14.11.2026
CVS Health says lower GLP-1 pricing could improve employer health plan costs
Employers and other health plan sponsors could break even on GLP-1 medicines if monthly prices fall below $350, as lower use of hospital and emergency services offsets more of the drug bill. CVS ...
  • Artem Shendetskii
  • 10.11.2026
CVS break-up underscores limits of M&A-led healthcare strategy
CVS is splitting its retail pharmacy business from its much larger health insurance arm after years of expansion across the U.S. healthcare chain. The move highlights mounting pressure on ...
  • Viktoras Karapetjanc
  • 06.11.2026
Why is CVS Health stock up 2.6% today?
CVS Health Corp (CVS) climbed 2.67% after the company announced plans to separate its retail pharmacy business from its insurance and pharmacy services operations, alongside better-than-expected ...
  • Dmytro Kharkov
  • 06.11.2026
CVS Health’s $117B split: Defensive spin-off or end of healthcare vertical integration?
​CVS plans to divide its $117 billion empire into several entities by 2028. This may affect 9,000 pharmacies as well as such brands as Aetna and Caremark. The decision is a response to ...
  • Artem Shendetskii
  • 06.11.2026
CVS Health insurance units face AM Best review after planned breakup
CVS Health is moving toward a two-company separation that prompts fresh scrutiny of key insurance ratings across its Aetna operations. The review covers Aetna Health & Life Group entities and CVS ...
  • Darina Pashchenko
  • 04.11.2026
CVS Health weighs retail pharmacy spin-off amid pressure on PBM-insurer ownership
Political and legal pressure on vertically integrated healthcare groups is pushing CVS Health to consider a split of its retail pharmacy operations from its insurance and pharmacy benefits ...
  • Olga Shendetskaya
  • 20.10.2026
CVS Health breakout setup highlights defensive momentum in healthcare
Healthcare stocks are extending a strong run as investors rotate toward defensive sectors in volatile markets. CVS Health is emerging as a technical candidate for a longer-term advance, with ...
  • Dmytro Kharkov
  • 19.10.2026
Goldman Sachs flags defensive stocks as AI-led market rally faces risks
With energy prices and interest rates pressuring the economic outlook, investors are reassessing how long the artificial intelligence-driven equity rally can keep supporting broader market gains. ...
  • Olga Shendetskaya
  • 13.10.2026
CVS agrees to pay $315 million in opioid and false claims settlement
Federal authorities are resolving a long-running case over how CVS handled opioid and other controlled-substance prescriptions across its pharmacy operations. The agreement covers alleged conduct ...
  • Olga Shendetskaya
  • 09.10.2026
Humana shares jump as 2027 Medicare ratings boost bonus payment outlook
Humana gains sharply in premarket trading after new U.S. Medicare star ratings position the insurer well for 2027 bonus payments and enrollment momentum. The company says 95% of its Medicare ...
  • Jainam Mehta
  • 07.10.2026
What's behind CVS Health's latest 3.6% stock surge?
CVS Health Corp (CVS) climbed 3.58% after a federal judge allowed a lawsuit over revenue inflation claims involving artificial intelligence to proceed, bringing renewed attention to ongoing legal ...
  • Parshwa Turakhiya
  • 01.10.2026
Cardinal Health shares rise after CVS distribution deal extension clears contract risk
Cardinal Health gains on Thursday after extending a key distribution relationship with CVS Health, easing a major uncertainty for investors as markets navigate higher Treasury yields and shifting ...
  • Ciaran Ryan
  • 24.09.2026
CVS Group posts revenue, EBITDA growth as Australia expands share of sales
Veterinary services provider CVS Group reports higher revenue and earnings for the year ended 30 June 2026, supported by like-for-like sales growth and a larger Australian business. The company ...
  • Daria Chernytska
  • 22.09.2026
Luxury brands seek runway boost as sector slowdown deepens in Milan and Paris
Luxury groups are using Milan and Paris Fashion Week to defend demand as weaker spending and geopolitical tensions cloud the outlook for high-end goods. Investors are watching whether costly ...
  • Ciaran Ryan
  • 06.08.2026
U.S. stocks face mixed trading as earnings moves hit storage shares and SpaceX lock-up expires
Investors are weighing a mixed set of corporate updates on Thursday as earnings reactions pressure parts of the technology sector and a large block of SpaceX shares becomes eligible to trade. The ...
  • Ashutosh Sureka
  • 05.08.2026
CVS Health raises 2026 profit forecast on stronger pharmacy mix and Aetna margins
CVS Health is lifting its annual profit outlook after a stronger second quarter supports its pharmacy and insurance operations. The upgrade comes as the company posts another earnings beat, ...
  • Dan Blystone
  • 14.07.2026
CVS Caremark settles FTC case over drug rebates and TrumpRx deductible credits
CVS Health's Caremark reaches a settlement with the U.S. Federal Trade Commission that targets rebate practices in the pharmacy benefits market. The agreement also requires the company to count ...
  • Ashutosh Sureka
  • 08.07.2026
Obamacare insurers seek steepest premium jump in years for 2027 plans
Rising medical costs and weaker enrollment are pushing insurers selling Affordable Care Act coverage to pursue sharply higher prices for next year. The requested 14% median premium increase over ...
  • Dan Blystone
  • 26.06.2026
Wall Street focus shifts to SpaceX, CVS and June sentiment data
U.S. equity investors are heading into Friday with attention on fresh stock-specific momentum and a key consumer sentiment release after the Nasdaq Composite posts a fourth straight daily decline. ...